Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8446 |
Intermediate Similarity |
NPD3405 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD9081 |
Clinical (unspecified phase) |
0.6839 |
Remote Similarity |
NPD5342 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.6803 |
Remote Similarity |
NPD1354 |
Approved |
0.6803 |
Remote Similarity |
NPD1356 |
Approved |
0.6803 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.679 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.677 |
Remote Similarity |
NPD1030 |
Approved |
0.677 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.677 |
Remote Similarity |
NPD1027 |
Approved |
0.6706 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD705 |
Clinical (unspecified phase) |
0.6643 |
Remote Similarity |
NPD9360 |
Approved |
0.6629 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.6629 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.6625 |
Remote Similarity |
NPD1690 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD515 |
Phase 1 |
0.6606 |
Remote Similarity |
NPD1290 |
Phase 2 |
0.6599 |
Remote Similarity |
NPD1389 |
Clinical (unspecified phase) |
0.6599 |
Remote Similarity |
NPD1390 |
Phase 1 |
0.6599 |
Remote Similarity |
NPD1388 |
Phase 1 |
0.6597 |
Remote Similarity |
NPD307 |
Approved |
0.6593 |
Remote Similarity |
NPD8641 |
Approved |
0.6593 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.6544 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.6519 |
Remote Similarity |
NPD459 |
Clinical (unspecified phase) |
0.6513 |
Remote Similarity |
NPD545 |
Clinical (unspecified phase) |
0.6503 |
Remote Similarity |
NPD536 |
Clinical (unspecified phase) |
0.6485 |
Remote Similarity |
NPD695 |
Discontinued |
0.6474 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6471 |
Remote Similarity |
NPD8629 |
Discontinued |
0.6464 |
Remote Similarity |
NPD1043 |
Phase 3 |
0.6453 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6433 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD1042 |
Clinical (unspecified phase) |
0.6406 |
Remote Similarity |
NPD6545 |
Clinical (unspecified phase) |
0.64 |
Remote Similarity |
NPD300 |
Approved |
0.6398 |
Remote Similarity |
NPD9724 |
Phase 1 |
0.6393 |
Remote Similarity |
NPD994 |
Phase 2 |
0.6393 |
Remote Similarity |
NPD996 |
Phase 2 |
0.6389 |
Remote Similarity |
NPD9132 |
Discontinued |
0.6364 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6358 |
Remote Similarity |
NPD775 |
Approved |
0.6352 |
Remote Similarity |
NPD1451 |
Approved |
0.6347 |
Remote Similarity |
NPD2604 |
Approved |
0.6347 |
Remote Similarity |
NPD3697 |
Discontinued |
0.6328 |
Remote Similarity |
NPD1327 |
Discontinued |
0.6319 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.6316 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6306 |
Remote Similarity |
NPD1808 |
Phase 1 |
0.6302 |
Remote Similarity |
NPD7834 |
Approved |
0.6301 |
Remote Similarity |
NPD237 |
Clinical (unspecified phase) |
0.6299 |
Remote Similarity |
NPD547 |
Clinical (unspecified phase) |
0.6298 |
Remote Similarity |
NPD706 |
Phase 1 |
0.6294 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6294 |
Remote Similarity |
NPD3130 |
Discontinued |
0.6286 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.6286 |
Remote Similarity |
NPD966 |
Clinical (unspecified phase) |
0.6282 |
Remote Similarity |
NPD1120 |
Approved |
0.6282 |
Remote Similarity |
NPD1121 |
Approved |
0.6269 |
Remote Similarity |
NPD7981 |
Discontinued |
0.6259 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.6258 |
Remote Similarity |
NPD209 |
Clinical (unspecified phase) |
0.6257 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD9183 |
Clinical (unspecified phase) |
0.6242 |
Remote Similarity |
NPD9133 |
Approved |
0.6224 |
Remote Similarity |
NPD9375 |
Discontinued |
0.6224 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.6222 |
Remote Similarity |
NPD4441 |
Phase 2 |
0.6216 |
Remote Similarity |
NPD2127 |
Suspended |
0.6205 |
Remote Similarity |
NPD7465 |
Suspended |
0.6193 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.6187 |
Remote Similarity |
NPD8861 |
Approved |
0.6187 |
Remote Similarity |
NPD8862 |
Approved |
0.6187 |
Remote Similarity |
NPD8859 |
Approved |
0.6186 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6185 |
Remote Similarity |
NPD509 |
Phase 3 |
0.6185 |
Remote Similarity |
NPD1313 |
Approved |
0.6185 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.6181 |
Remote Similarity |
NPD7980 |
Clinical (unspecified phase) |
0.6175 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6175 |
Remote Similarity |
NPD2009 |
Clinical (unspecified phase) |
0.6166 |
Remote Similarity |
NPD6403 |
Clinical (unspecified phase) |
0.6158 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6158 |
Remote Similarity |
NPD2928 |
Phase 2 |
0.6158 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6149 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.6145 |
Remote Similarity |
NPD5730 |
Phase 2 |
0.6145 |
Remote Similarity |
NPD40 |
Phase 2 |
0.6145 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6139 |
Remote Similarity |
NPD9628 |
Approved |
0.6138 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.6138 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.6136 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6131 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.6125 |
Remote Similarity |
NPD875 |
Clinical (unspecified phase) |
0.6124 |
Remote Similarity |
NPD5943 |
Clinical (unspecified phase) |
0.6122 |
Remote Similarity |
NPD8261 |
Discontinued |
0.612 |
Remote Similarity |
NPD2872 |
Phase 2 |
0.612 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.612 |
Remote Similarity |
NPD2793 |
Discontinued |
0.6118 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.6114 |
Remote Similarity |
NPD6906 |
Clinical (unspecified phase) |
0.6111 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.6096 |
Remote Similarity |
NPD9374 |
Approved |
0.6096 |
Remote Similarity |
NPD460 |
Discontinued |
0.6095 |
Remote Similarity |
NPD3906 |
Approved |
0.6092 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6091 |
Remote Similarity |
NPD949 |
Phase 1 |
0.6089 |
Remote Similarity |
NPD3041 |
Approved |
0.6087 |
Remote Similarity |
NPD1431 |
Approved |
0.6087 |
Remote Similarity |
NPD1430 |
Approved |
0.6085 |
Remote Similarity |
NPD3830 |
Phase 1 |
0.6075 |
Remote Similarity |
NPD7709 |
Discontinued |
0.6069 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6069 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6051 |
Remote Similarity |
NPD796 |
Phase 2 |
0.6048 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.6045 |
Remote Similarity |
NPD3105 |
Discontinued |
0.6043 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.604 |
Remote Similarity |
NPD8105 |
Discontinued |
0.6036 |
Remote Similarity |
NPD2662 |
Approved |
0.6036 |
Remote Similarity |
NPD2180 |
Approved |
0.6036 |
Remote Similarity |
NPD2660 |
Approved |
0.6033 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.602 |
Remote Similarity |
NPD8271 |
Discontinued |
0.6014 |
Remote Similarity |
NPD1368 |
Approved |
0.6012 |
Remote Similarity |
NPD174 |
Discontinued |
0.6011 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6011 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6011 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.601 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD9409 |
Discontinued |
0.6 |
Remote Similarity |
NPD2880 |
Discontinued |
0.599 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.5989 |
Remote Similarity |
NPD1895 |
Discontinued |
0.5978 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.5976 |
Remote Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.5967 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.5966 |
Remote Similarity |
NPD6794 |
Approved |
0.5959 |
Remote Similarity |
NPD9373 |
Approved |
0.5957 |
Remote Similarity |
NPD341 |
Approved |
0.5957 |
Remote Similarity |
NPD340 |
Approved |
0.5957 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.5955 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.5955 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.5951 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5949 |
Remote Similarity |
NPD1915 |
Phase 1 |
0.5941 |
Remote Similarity |
NPD7471 |
Discontinued |
0.5938 |
Remote Similarity |
NPD3814 |
Phase 1 |
0.5934 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.5933 |
Remote Similarity |
NPD9607 |
Approved |
0.5932 |
Remote Similarity |
NPD9582 |
Phase 3 |
0.593 |
Remote Similarity |
NPD4863 |
Approved |
0.5922 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.592 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.5909 |
Remote Similarity |
NPD2786 |
Discontinued |
0.5909 |
Remote Similarity |
NPD3889 |
Approved |
0.5904 |
Remote Similarity |
NPD2892 |
Phase 1 |
0.5904 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.5904 |
Remote Similarity |
NPD1286 |
Suspended |
0.5902 |
Remote Similarity |
NPD4414 |
Discontinued |
0.59 |
Remote Similarity |
NPD2794 |
Discontinued |
0.5897 |
Remote Similarity |
NPD2364 |
Suspended |
0.5895 |
Remote Similarity |
NPD978 |
Clinical (unspecified phase) |
0.5889 |
Remote Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.5889 |
Remote Similarity |
NPD4128 |
Approved |
0.5885 |
Remote Similarity |
NPD5885 |
Approved |
0.5882 |
Remote Similarity |
NPD7884 |
Discontinued |
0.5879 |
Remote Similarity |
NPD9627 |
Approved |
0.5879 |
Remote Similarity |
NPD3013 |
Phase 3 |
0.5879 |
Remote Similarity |
NPD3014 |
Clinical (unspecified phase) |
0.5876 |
Remote Similarity |
NPD1215 |
Discontinued |
0.5875 |
Remote Similarity |
NPD809 |
Discontinued |
0.5874 |
Remote Similarity |
NPD9291 |
Approved |
0.587 |
Remote Similarity |
NPD3512 |
Clinical (unspecified phase) |
0.5867 |
Remote Similarity |
NPD9606 |
Approved |
0.5862 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.5862 |
Remote Similarity |
NPD8257 |
Approved |
0.5862 |
Remote Similarity |
NPD8256 |
Approved |
0.586 |
Remote Similarity |
NPD3913 |
Clinical (unspecified phase) |
0.5849 |
Remote Similarity |
NPD7415 |
Suspended |
0.5848 |
Remote Similarity |
NPD2524 |
Discontinued |
0.5848 |
Remote Similarity |
NPD1257 |
Approved |
0.5842 |
Remote Similarity |
NPD3403 |
Clinical (unspecified phase) |
0.5839 |
Remote Similarity |
NPD8838 |
Approved |
0.5838 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.5838 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.5838 |
Remote Similarity |
NPD1709 |
Phase 1 |
0.5825 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.5824 |
Remote Similarity |
NPD2293 |
Phase 2 |
0.5822 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.5818 |
Remote Similarity |
NPD724 |
Approved |
0.5813 |
Remote Similarity |
NPD194 |
Clinical (unspecified phase) |
0.5806 |
Remote Similarity |
NPD415 |
Discontinued |
0.5805 |
Remote Similarity |
NPD4555 |
Clinical (unspecified phase) |
0.5805 |
Remote Similarity |
NPD5300 |
Clinical (unspecified phase) |
0.5803
|
Remote Similarity |
NPD3287 |
Clinical (unspecified phase) |